iRadimed (IRMD) Q3 2024 Earnings
IRMD·Reported October 31, 2024·Before market open
iRadimed reported Q3 2024 revenue of $18.3M, missed analyst consensus of $18.9M by $614.0K. Diluted EPS came in at $0.43, beat the $0.39 consensus by $0.04.
Revenue
$18.3Mmissed by $614.0K
Consensus: $18.9MDiluted EPS
$0.43beat by $0.04
Consensus: $0.39
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about iRadimed's Q3 2024 earnings report.
iRadimed (IRMD) reported Q3 2024 earnings on October 31, 2024 before market open.
iRadimed reported revenue of $18.3M and diluted EPS of $0.43 for Q3 2024.
Revenue missed the consensus estimate of $18.9M by $614.0K. EPS beat the consensus estimate of $0.39 by $0.04.
You can read the 10-Q periodic report (0001558370-24-014056) directly on SEC EDGAR. The filing index links above go to sec.gov.